Planning clinically relevant biomarker validation studies using the “number needed to treat” concept
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Day, Roger S.
Funding for this research was provided by:
U.S. National Library of Medicine (R01 LM 010144)
National Cancer Institute (P50 CA121973, P30 CA047904)
U.S. Department of Defense (W81XWH-05- 2-0005, W81XWH-11-2-013)